Related Experiment Video

Updated: Feb 16, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.7K

Algorithm of Molecular and Biological Assessment of the Mechanisms of Sensitivity to Drug Toxicity by the Example of

L Yu Telegin1, S Kh Sarmanaev2, V M Devichenskii2

  • 1Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, Moscow, Russia. tell2003@post.ru.

Bulletin of Experimental Biology and Medicine
|January 9, 2018
PubMed

Insights

This study identified key biomarkers for cyclophosphamide toxicity in mice. These findings can help create a system to assess the toxic effects of various substances.

Area of Science:

  • Toxicology
  • Pharmacology
  • Biomarker Discovery

Background:

  • Cyclophosphamide is an important antitumor and immunosuppressive drug.
  • Understanding its acute toxicity is crucial for patient safety and drug development.
  • Variations in sensitivity to cyclophosphamide exist among different mouse strains.

Purpose of the Study:

  • To identify reliable toxicity biomarkers for cyclophosphamide.
  • To compare toxic effects in sensitive versus resistant mouse models.
  • To lay the groundwork for an algorithm evaluating drug and food component toxicity.

Main Methods:

  • Comparative analysis of liver, blood, and spleen tissues.
  • Utilized DBA/2JSto (sensitive) and BALB/cJLacSto (resistant) mouse strains.
  • Focused on acute toxicity assessment.

Main Results:

  • Identified specific biomarkers indicative of cyclophosphamide-induced toxicity.
  • Demonstrated differences in toxicity manifestation between sensitive and resistant mouse strains.
  • Established a foundation for quantitative toxicity evaluation.

Conclusions:

  • The study successfully identified critical biomarkers for cyclophosphamide toxicity.
  • These biomarkers can be instrumental in developing predictive toxicity assessment tools.
  • The findings have implications for evaluating the safety of pharmaceuticals and dietary components.
Keywords:
BALB/cJLacSto and DBA/2JSto miceacute toxicitybiomarkerscyclophosphamide

More Related Videos

Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain05:10

Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain

Published on: August 30, 2022

3.5K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.4K

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
22
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
18
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
18
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
21
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
16
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
19